AF without thrombus | AF with thrombus | p-value | |
---|---|---|---|
(n = 217) | (n = 43) | ||
Clinical parameters | |||
Age (year) | 65.9 ± 10.5 | 68.9 ± 9.7 | 0.08 |
Male, n (%) | 165 (76) | 35 (81) | 0.41 |
Smoking, n (%) | 51 (23) | 10 (23) | 0.98 |
Diabetes Mellitus, n (%) | 45 (21) | 13 (30) | 0.17 |
Hypertension, n (%) | 128 (59) | 31 (72) | 0.10 |
Dyslipidemia, n (%) | 59 (27) | 7 (16) | 0.13 |
Prior stroke, n (%) | 25 (12) | 11 (26) | 0.015 |
AF duration (year) | 5.9 ± 5.8 | 7.1 ± 5.9 | 0.22 |
PT-INR | 1.89 ± 0.47 | 1.91 ± 0.44 | 0.81 |
PT-INR met guideline | 132 (61) | 31 (72) | 0.16 |
CHADS2 score | 1 (1 – 2) | 2 (1 – 3) | 0.003 |
Echocardiographic parameters | |||
LVEF (%) | 57.7 ± 9.2 | 55.7 ± 9.0 | 0.19 |
LAD (mm) | 46.7 ± 6.5 | 49.0 ± 6.1 | 0.032 |
Maximum LAA volume (ml) | 10.6 ± 4.7 | 17.4 ± 9.9 | <0.001 |
Minimum LAA volume (ml) | 7.4 ± 3.8 | 14.2 ± 8.4 | <0.001 |
SEC score (0-4 grade) | 1 (1 – 1) | 1 (1 – 2) | <0.001 |
LAAPV (cm/sec) | 29.6 ± 11.4 | 21.2 ± 6.6 | <0.001 |
LAA peak longitudinal strain | 8.2 ± 5.0 | 2.7 ± 1.9 | <0.001 |
LAAEF (%) | 31.3 ± 10.5 | 18.5 ± 4.2 | <0.001 |